HIV clinical trials unit serving Cleveland, Cincinnati, and Kampala
Official title: Case Clinical Trials Unit
Funded at Case Western Reserve University · NIH-11456877 · Data updated 2026-11-12
This program runs HIV treatment, vaccine, and related studies for adults living with or at risk for HIV.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Case Western Reserve University NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project start | February 13, 2007 |
| Project end | November 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $479,119 |
| NIH project number | 3UM1AI069501-20S1 |
| Project ID | NIH-11456877 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults (typically 21 years and older) living with HIV or at risk for HIV who can attend visits at one of the participating sites are the usual candidates.
✕Less likely to help
Children under site age cutoffs, people unable to travel to the listed locations, or those who do not meet specific study eligibility rules may not benefit or be eligible.
What this research studies
This multi-site clinical research unit brings together Case Western Reserve, the University of Cincinnati, and the Joint Clinical Research Center in Kampala to run HIV treatment and prevention studies. You might be invited to join trials of antiretroviral drugs, vaccine studies, or research on HIV-related conditions like tuberculosis, hepatitis, and inflammation. Staff link clinic work with laboratory testing, including immune monitoring and translational science, and they enroll people from diverse and hard-to-reach communities. If you participate, you would follow study visits at one of the sites and may provide samples or clinical data for the research.
Why it matters
Potential benefit: If successful, the program could improve HIV treatments, prevention tools, and advance efforts toward cure and better management of co-infections.
How similar studies have gone: Groups like the ACTG and HVTN have produced many important HIV treatment and prevention advances, though cure and some vaccine approaches remain experimental.
Where this research is happening
-
Case Western Reserve University
Cleveland, United States Active
Researchers
- Principal investigator: Yendewa, George — Case Western Reserve University
- Study coordinator: Yendewa, George
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.